AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2015
Nov 6, 2015
30786_dirs_2015-11-05_49192300-c04e-4cb3-841d-488aa076aa6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-11-04
Reporting Person: STARK JAMES R (VP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-04 | Bio-Rad A Common Stock | M | 200 | — | Acquired | 696 | Direct |
| 2015-11-04 | Bio-Rad A Common Stock | F | 76 | $140.86 | Disposed | 620 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-04 | Restricted Stock Units | $0 | M | 200 | Disposed | Bio-Rad A Common Stock (200) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest in five equal annual installments beginning November 4, 2012.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13